HighTower Advisors’s Alpha Tau Medical DRTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11M Hold
874,994
0.01% 898
2026
Q1
$6.19M Buy
874,994
+188,440
+27% +$1.33M 0.01% 1094
2025
Q4
$3.4M Hold
686,554
﹤0.01% 1373
2025
Q3
$3.1M Hold
686,554
﹤0.01% 1388
2025
Q2
$2.14M Buy
686,554
+455,850
+198% +$1.28M ﹤0.01% 1526
2025
Q1
$579K Hold
230,704
﹤0.01% 2336
2024
Q4
$715K Hold
230,704
﹤0.01% 2204
2024
Q3
$549K Hold
230,704
﹤0.01% 2332
2024
Q2
$584K Buy
230,704
+18,196
+9% +$46.3K ﹤0.01% 2209
2024
Q1
$627K Hold
212,508
﹤0.01% 2113
2023
Q4
$639K Buy
+212,508
New +$684K ﹤0.01% 2146

Other funds holding DRTS

HighTower Advisors's DRTS Position: Q2 2026 in Review

HighTower Advisors held its Alpha Tau Medical (DRTS) position steady in Q2 2026 at 874,994 shares worth $11M. The position accounts for 0.01% of the portfolio, ranked #898.

HighTower Advisors first reported a position in DRTS in Q4 2023 and has held it in 11 quarters since. 74 funds tracked by Wall St. Rank hold DRTS as of Q2 2026.

  • HighTower Advisors held 874,994 shares of Alpha Tau Medical worth $11M as of Q2 2026.
  • HighTower Advisors left its Alpha Tau Medical share count unchanged in Q2 2026.
  • Alpha Tau Medical made up 0.01% of HighTower Advisors's portfolio in Q2 2026, its #898 holding.
  • HighTower Advisors first reported a position in Alpha Tau Medical in Q4 2023 and has held it in 11 quarters since.
  • 74 funds tracked by Wall St. Rank held Alpha Tau Medical as of Q2 2026.

Based on HighTower Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.